Published in J Bacteriol on June 01, 1970
Molecular basis for cytadsorption of Mycoplasma pneumoniae. J Bacteriol (1982) 5.52
Relationships Between Mycoplasma pneumoniae and Human Respiratory Epithelium. Infect Immun (1971) 4.14
Serological cross-reactions between Mycoplasma genitalium and Mycoplasma pneumoniae. J Clin Microbiol (1984) 3.15
Cell biology of the mycoplasmas. Bacteriol Rev (1972) 2.75
Morphology, ultrastructure, and bacteriophage infection of the helical mycoplasma-like organism (Spiroplasma citri gen. nov., sp. nov.) cultured from "stubborn" disease of citrus. J Bacteriol (1973) 2.57
Reacquisition of specific proteins confers virulence in Mycoplasma pneumoniae. Infect Immun (1983) 2.36
Ultrastructural study of Mycoplasma pneumoniae in organ culture. J Bacteriol (1976) 2.08
Inhibition of mycoplasma pneumoniae hemadsorption and adherence to respiratory epithelium by antibodies to a membrane protein. Infect Immun (1983) 2.00
Intracellular structures of Mycoplasma pneumoniae revealed after membrane removal. J Bacteriol (1980) 1.98
Visualization of the attachment organelle and cytadherence proteins of Mycoplasma pneumoniae by immunofluorescence microscopy. J Bacteriol (2001) 1.95
Filamentous structures in adherent Mycoplasma pneumoniae cells treated with nonionic detergents. J Cell Biol (1981) 1.79
Localization of the Mycoplasma pneumoniae cytadherence-accessory proteins HMW1 and HMW4 in the cytoskeletonlike Triton shell. J Bacteriol (1991) 1.68
Morphology and ultrastructure of Mycoplasma pneumoniae spherules. J Bacteriol (1971) 1.68
Interaction of Mycoplasma pneumoniae with human lung fibroblasts: characterization of the in vitro model. Infect Immun (1979) 1.62
Mycoplasma pneumoniae protein P30 is required for cytadherence and associated with proper cell development. J Bacteriol (1999) 1.62
Attachment organelle formation represented by localization of cytadherence proteins and formation of the electron-dense core in wild-type and mutant strains of Mycoplasma pneumoniae. J Bacteriol (2003) 1.51
Mycoplasma pneumoniae cytadherence phase-variable protein HMW3 is a component of the attachment organelle. J Bacteriol (1992) 1.48
Use of fluorescent-protein tagging to determine the subcellular localization of mycoplasma pneumoniae proteins encoded by the cytadherence regulatory locus. J Bacteriol (2004) 1.40
Loss of HMW1 and HMW3 in noncytadhering mutants of Mycoplasma pneumoniae occurs post-translationally. Proc Natl Acad Sci U S A (1997) 1.39
Extraction of an actin-like protein from the prokaryote Mycoplasma pneumoniae. Proc Natl Acad Sci U S A (1977) 1.38
Identification of a possible cytadherence regulatory locus in Mycoplasma pneumoniae. Infect Immun (1995) 1.35
Absence of Mycoplasma pneumoniae cytadsorption protein P1 in Mycoplasma genitalium and Mycoplasma gallisepticum. Infect Immun (1984) 1.28
Electron microscopic studies on the attachment of Mycoplasma pneumoniae to guinea pig erythrocytes. Infect Immun (1979) 1.27
Detection of the major adhesin P1 in triton shells of virulent Mycoplasma pneumoniae. Infect Immun (1985) 1.26
Intracellular location of Mycoplasma genitalium in cultured Vero cells as demonstrated by electron microscopy. Int J Exp Pathol (1994) 1.23
Interaction of mycoplasmas with cell cultures, as visualized by electron microscopy. Proc Natl Acad Sci U S A (1974) 1.23
Cytoskeletal "jellyfish" structure of Mycoplasma mobile. Proc Natl Acad Sci U S A (2007) 1.21
Mutant analysis reveals a specific requirement for protein P30 in Mycoplasma pneumoniae gliding motility. J Bacteriol (2005) 1.20
Nucleotide sequence analysis reveals novel features of the phase-variable cytadherence accessory protein HMW3 of Mycoplasma pneumoniae. Infect Immun (1992) 1.16
Cultivation of Mycoplasmas on glass. Appl Microbiol (1971) 1.15
The immunodominant 90-kilodalton protein is localized on the terminal tip structure of Mycoplasma pneumoniae. Infect Immun (1993) 1.15
Transposon mutagenesis identifies genes associated with Mycoplasma pneumoniae gliding motility. J Bacteriol (2006) 1.15
Phosphorylation of cytadherence-accessory proteins in Mycoplasma pneumoniae. J Bacteriol (1994) 1.14
Terminal organelle development in the cell wall-less bacterium Mycoplasma pneumoniae. Proc Natl Acad Sci U S A (2006) 1.14
Protein P200 is dispensable for Mycoplasma pneumoniae hemadsorption but not gliding motility or colonization of differentiated bronchial epithelium. Infect Immun (2006) 1.11
The Harrison Lecture. The history and role of Mycoplasma genitalium in sexually transmitted diseases. Genitourin Med (1995) 1.08
Immune electron microscopy of cross-reactions between Mycoplasma pneumoniae and human erythrocytes. Infect Immun (1979) 1.05
Occurrence and ultrastructure of a variant (rho) form of Mycoplasma. J Bacteriol (1973) 1.02
HMW1 is required for stability and localization of HMW2 to the attachment organelle of Mycoplasma pneumoniae. J Bacteriol (2004) 0.99
Characterization of a Mycoplasma pneumoniae hmw3 mutant: implications for attachment organelle assembly. J Bacteriol (2002) 0.99
Domain analysis of protein P30 in Mycoplasma pneumoniae cytadherence and gliding motility. J Bacteriol (2011) 0.97
Mycoplasma pneumoniae in hamster tracheal organ culture studied by scanning electron microscopy. Infect Immun (1976) 0.97
Electron microscopy of Mycoplasma pneumoniae microcolonies grown on solid surfaces. Appl Environ Microbiol (1977) 0.95
Influence of cell shape and surface charge on attachment of Mycoplasma pneumoniae to glass surfaces. J Bacteriol (1983) 0.94
Freeze-fracture confirmation of the presence of a core in the specialized tip structure of Mycoplasma pneumoniae. J Bacteriol (1983) 0.93
Partitioning, movement, and positioning of nucleoids in Mycoplasma capricolum. J Bacteriol (1999) 0.91
Ultrastructural lesions in Mycoplasma pneumoniae membranes produced by antibody and complement. Infect Immun (1973) 0.89
Phosphorylation of Mycoplasma pneumoniae cytadherence-accessory proteins in cell extracts. J Bacteriol (1995) 0.89
Scanning electron microscopy of mycoplasmas adhering to erythrocytes. Infect Immun (1980) 0.87
Cell reproduction and morphological changes in Mycoplasma capricolum. J Bacteriol (1998) 0.87
Mycoplasma pneumoniae cytoskeletal protein HMW2 and the architecture of the terminal organelle. J Bacteriol (2009) 0.85
Conserved terminal organelle morphology and function in Mycoplasma penetrans and Mycoplasma iowae. J Bacteriol (2012) 0.85
Processing is required for a fully functional protein P30 in Mycoplasma pneumoniae gliding and cytadherence. J Bacteriol (2011) 0.84
P65 truncation impacts P30 dynamics during Mycoplasma pneumoniae gliding. J Bacteriol (2012) 0.81
Novel cellular organization in a gliding mycoplasma, Mycoplasma insons. J Bacteriol (2009) 0.80
Pathogenicity and cytadherence of Mycoplasma imitans in chicken and duck embryo tracheal organ cultures. Infect Immun (1996) 0.80
Mycoplasma and bacterial proteins resembling contractile proteins: a review. Yale J Biol Med (1984) 0.80
Insights into the function of Mycoplasma pneumoniae protein P30 from orthologous gene replacement. Microbiology (2011) 0.78
Location of attachment moiety on Mycoplasma pneumoniae. Yale J Biol Med (1984) 0.78
Loss of co-chaperone TopJ impacts adhesin P1 presentation and terminal organelle maturation in Mycoplasma pneumoniae. Mol Microbiol (2011) 0.77
[Ultrastructural changes of human tumours after transfer into laboratory animals. I. Malignant melanoma (4 cases) (author's transl)]. Arch Dermatol Forsch (1973) 0.77
P40 and P90 from Mpn142 are Targets of Multiple Processing Events on the Surface of Mycoplasma pneumoniae. Proteomes (2015) 0.75
Positive detection of mycoplasma contamination by the whole-mount preparation of cell cultures for transmission electron microscopy. J Bacteriol (1978) 0.75
Influence of the fusogenic agent polyethylene glycol on attachment of Mycoplasma pneumoniae to other cells. Infect Immun (1981) 0.75
Biological database of images and genomes: tools for community annotations linking image and genomic information. Database (Oxford) (2013) 0.75
A SIMPLIFIED LEAD CITRATE STAIN FOR USE IN ELECTRON MICROSCOPY. J Cell Biol (1965) 37.37
PLASTIC EMBEDDING MIXTURES FOR USE IN ELECTRON MICROSCOPY. Stain Technol (1964) 17.91
AN IMPROVED STAINING METHOD FOR ELECTRON MICROSCOPY. J Cell Biol (1964) 7.33
MYCOPLASMA SPECIES OF MAN. Bacteriol Rev (1965) 4.41
ULTRASTRUCTURE OF MYCOPLASMA SPECIES. J Bacteriol (1964) 3.81
The interaction of mycoplasmas with mammalian cells. I. HeLa cells, neutrophils, and eosinophils. J Exp Med (1966) 3.38
Growth of Mycoplasma pneumoniae on a glass surface. Ann N Y Acad Sci (1967) 3.31
Growth morphology of Mycoplasma pneumoniae strain FH on glass surface. Proc Soc Exp Biol Med (1968) 2.77
Phase-contrast and electron microscopy of murine strains of Mycoplasma. J Bacteriol (1965) 2.46
Motility and multiplication of Mycoplasma pneumoniae. A phase contrast study. Pathol Microbiol (Basel) (1968) 2.33
Adherence of mycoplasmas to glass and plastic. J Bacteriol (1967) 2.24
Analysis of the life cycle of Mycoplasma pneumoniae by synchronized division and by ultraviolet and x irradiations. J Infect Dis (1968) 2.03
Physical properties of human Mycoplasma species. J Bacteriol (1966) 1.68
[Morphology and growth of Mycoplasma pneumoniae on glass observed with phase contrast microscope]. Zentralbl Bakteriol Orig (1968) 1.19
Morphological observations on lymphocyte peripolesis and cytotoxic action in vitro. Exp Cell Res (1968) 0.95
Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science (1986) 8.15
Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet (1986) 7.09
A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma. Nat Med (1995) 3.30
AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science (1989) 2.93
HIV counseling and testing of pregnant women in sub-Saharan Africa: experiences from a study on prevention of mother-to-child HIV-1 transmission in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr (2001) 2.81
Antibodies to brain and other tissues in cases of Mycoplasma pneumoniae infection. Clin Exp Immunol (1971) 2.76
The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2. Nat Cell Biol (2000) 2.36
Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells. Science (1988) 2.30
Target-effector interaction in the natural killer (NK) cell system. II. The isolation of NK cells and studies on the mechanism of killing. J Immunol (1978) 2.29
Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys. Nature (1991) 2.28
Anti-actin specificity of human smooth muscle antibodies in chronic active hepatitis. Clin Exp Immunol (1976) 2.24
Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells. J Natl Cancer Inst (1999) 2.18
Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. Science (1988) 2.17
Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. Karolinska Institute Primary HIV Infection Study Group. AIDS (2000) 2.08
Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection. J Virol (1987) 1.99
The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors. J Exp Med (1999) 1.98
New human and simian HIV-related retroviruses possess functional transactivator (tat) gene. Nature (1987) 1.93
HTLV-III expression in infected lymph nodes and relevance to pathogenesis of lymphadenopathy. Am J Pathol (1986) 1.88
Mycoplasma pneumoniae is a polyclonal B-cell activator. Nature (1976) 1.83
Intracerebral inflammation after human brain contusion. Neurosurgery (1998) 1.82
Comparison of in-house and commercial sample preparation and PCR amplification systems for detection of human immunodeficiency virus type 1 DNA in blood samples from Tanzanian adults. J Clin Microbiol (1997) 1.76
Specifically cytotoxic lymphocytes produced by preincubation with antibody-complexed target cells. J Immunol (1972) 1.74
Differentiation of human dendritic cells from monocytes in vitro. Eur J Immunol (1997) 1.72
Monitoring of HIV-1 infection prevalence and trends in the general population using pregnant women as a sentinel population: 9 years experience from the Kagera region of Tanzania. J Acquir Immune Defic Syndr (2000) 1.70
A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II, and HTLV-IIIB. AIDS Res Hum Retroviruses (1987) 1.67
Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma. Int J Cancer (1997) 1.65
Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages. J Immunol (1987) 1.61
Discrimination between antibodies to HIV and to related retroviruses using site-directed serology. Nature (1987) 1.59
Reaction of human smooth muscle antibodies with human blood lymphocytes and lymphoid cell lines. Nature (1974) 1.54
Blood donor sera with false-positive Western blot reactions to human immunodeficiency virus. Lancet (1986) 1.53
The mixed haemadsorption test as an aid to the diagnosis of thyroid autoimmune disease. Clin Exp Immunol (1968) 1.52
Molecular and biological characterization of a replication competent human immunodeficiency type 2 (HIV-2) proviral clone. Proc Natl Acad Sci U S A (1989) 1.48
Uropod formation in phytohaemagglutinin (PHA) stimulated lymphocytes. Exp Cell Res (1971) 1.47
Lymphocyte subset enumeration in HIV seronegative and HIV-1 seropositive adults in Dar es Salaam, Tanzania: determination of reference values in males and females and comparison of two flow cytometric methods. J Immunol Methods (2003) 1.45
Central nervous system complications of Mycoplasma pneumoniae infection. Scand J Infect Dis (1969) 1.41
Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa? AIDS (2005) 1.41
Evaluation of 14 commercial HIV-1/HIV-2 antibody assays using serum panels of different geographical origin and clinical stage including a unique seroconversion panel. J Virol Methods (1998) 1.39
MALA-2, mouse homologue of human adhesion molecule ICAM-1 (CD54). Eur J Immunol (1989) 1.37
T-lymphocyte subpopulations in relation to immunosuppression in measles and varicella. Infect Immun (1983) 1.37
Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection. Arch Intern Med (2000) 1.37
Protection against mucosal SIVsm challenge in macaques infected with a chimeric SIV that expresses HIV type 1 envelope. AIDS Res Hum Retroviruses (1996) 1.36
Immunohistopathology of lymph nodes in HTLV-III infected homosexuals with persistent adenopathy or AIDS. Cancer Res (1985) 1.36
Performance of a modified HIV-1 p24 antigen assay for early diagnosis of HIV-1 infection in infants and prediction of mother-to-infant transmission of HIV-1 in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.34
Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6). Int J Cancer (1988) 1.34
Oral candida albicans in HIV infection. Scand J Infect Dis (1987) 1.31
Field evaluation of alternative testing strategies for diagnosis and differentiation of HIV-1 and HIV-2 infections in an HIV-1 and HIV-2-prevalent area. AIDS (1997) 1.31
Immunological changes in primary HIV-1 infection. AIDS (1990) 1.30
Kaposi's sarcoma-associated herpesvirus-encoded v-cyclin triggers apoptosis in cells with high levels of cyclin-dependent kinase 6. Cancer Res (1999) 1.28
Live attenuated simian immunodeficiency virus (SIV)mac in macaques can induce protection against mucosal infection with SIVsm. AIDS (1998) 1.27
Evaluation of the FACScount, TRAx CD4 and Dynabeads methods for CD4 lymphocyte determination. J Immunol Methods (1996) 1.27
Prevalence of HIV-1 infection in the Kagera region of Tanzania: a population-based study. AIDS (1990) 1.26
Reaction of human smooth muscle antibody with thyroid cells. Clin Exp Immunol (1974) 1.24
The distribution of HLA on human lymphoid, bone marrow and peripheral blood cells. Eur J Immunol (1979) 1.23
Morphological observations on the cytotoxicity of human bood lymphocytes for antibody-coated chicken erythrocytes. Exp Cell Res (1970) 1.22
The effect of irradiation on T-cell suppression of ELISA-determined Ig production by human blood B-cells in vitro. Clin Exp Immunol (1979) 1.22
Increased occurrence of cytoplasmic filaments in in vitro propagated rat liver epithelial cells. Exp Cell Res (1965) 1.22
Reaction of human smooth muscle antibody with thymus medullary cells. Nat New Biol (1973) 1.22
An immunohistological study of human lymphoma. Clin Exp Immunol (1980) 1.21
Histopathology and immunohistology of HTLV-III/LAV related lymphadenopathy and AIDS. Acta Pathol Microbiol Immunol Scand A (1987) 1.21
IgG antibodies to human herpesvirus-6 in children and adults and in primary Epstein-Barr virus infections and cytomegalovirus infections [corrected]. J Virol Methods (1988) 1.20
Immunohistology of skin pathergy reaction in Behçet's disease. Br J Dermatol (1995) 1.19
Trends and interaction of HIV-1 and HIV-2 in Guinea-Bissau, west Africa: no protection of HIV-2 against HIV-1 infection. AIDS (1999) 1.19
Impaired specific cellular response to HTLV-III before other immune defects in patients with HTLV-III infection. N Engl J Med (1986) 1.18
Smooth muscle antibodies in Mycoplasma pneumoniae infection. Clin Exp Immunol (1976) 1.17
Technical aspects of lymphoma immunohistology. J Histochem Cytochem (1980) 1.17
Antibodies in bronchial secretions following natural infection with Mycoplasma pneumoniae. Acta Pathol Microbiol Scand B Microbiol Immunol (1971) 1.16
Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus. AIDS Res Hum Retroviruses (1997) 1.16
Vaccine protection against HIV-2 infection in cynomolgus monkeys. AIDS Res Hum Retroviruses (1991) 1.16
Experimental infection of cynomolgus monkeys (Macaca fascicularis) with HIV-2. J Acquir Immune Defic Syndr (1989) 1.16
Activation of human lymphocyte subpopulations by Mycoplasma pneumoniae. Scand J Immunol (1977) 1.14
The accuracy of an alternative confirmatory strategy for detection of antibodies to HIV-1: experience from a regional laboratory in Kagera, Tanzania. J Clin Virol (1999) 1.14
Immunohistochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma. Hepatogastroenterology (2001) 1.13
Cell proliferation and DNA content in non-Hodgkin's lymphoma. Flow cytometry in relation to lymphoma classification. Cancer (1986) 1.13
Immunogenicity and protective efficacy of a human immunodeficiency virus type 2 recombinant canarypox (ALVAC) vaccine candidate in cynomolgus monkeys. J Infect Dis (1996) 1.13
Circulating immune complexes in Mycoplasma pneumoniae infection. J Immunol (1974) 1.13
Site-directed ELISA with synthetic peptides representing the HIV transmembrane glycoprotein. J Med Virol (1987) 1.13
Optimal blood mononuclear cell isolation procedures for gamma interferon enzyme-linked immunospot testing of healthy Swedish and Tanzanian subjects. Clin Vaccine Immunol (2008) 1.13
Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection. Virology (1993) 1.11
Specific and non-specific B cell activation in measles and varicella. Clin Exp Immunol (1983) 1.11
Acceptability of voluntary HIV testing with counselling in a rural village in Kagera, Tanzania. AIDS Care (1998) 1.11
A prospective study of vertical transmission of HIV-2 in Bissau, Guinea-Bissau. AIDS (1993) 1.11
Evaluation of commercial enzyme immunoassays for anti-HIV-1 using East African sera. AIDS (1988) 1.11
Protection of human immunodeficiency virus type 2-exposed seronegative macaques from mucosal simian immunodeficiency virus transmission. J Virol (1997) 1.11
Trypanosoma cruzi infection in tumor necrosis factor receptor p55-deficient mice. Infect Immun (1998) 1.10
Enhancing adherence to antiretroviral therapy at the HIV clinic in resource constrained countries; the Tanzanian experience. Trop Med Int Health (2009) 1.10
Prognostic information from cytogenetic analysis in chronic B-lymphocytic leukemia and leukemic immunocytoma. Blood (1985) 1.08
Cytotoxic interaction of phytohemagglutinin-stimulated blood lymphocytes with monolayer cells: a study by light and electron microscopy. Cell Immunol (1971) 1.08
Prevalence of HIV infection among hospital patients in north west Tanzania. AIDS Care (1999) 1.07
Heterogeneity of spindle cells in Kaposi's sarcoma: comparison of cells in lesions and in culture. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.07
Intracerebral inflammatory response to experimental brain contusion. Acta Neurochir (Wien) (1995) 1.06
Alternative confirmatory strategies in HIV-1 antibody testing. J Acquir Immune Defic Syndr (1992) 1.06
Mycoplasma pneumoniae infection in hospitalized patients with acute respiratory illness. Acta Pathol Microbiol Scand (1968) 1.06
Affordable CD4+ T cell counts by flow cytometry. II. The use of fixed whole blood in resource-poor settings. J Immunol Methods (2001) 1.05